loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 211673 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 NABRIVA (1)

filter

01 SOLUTION;INTRAVENOUS (1)

filter

01 DISCN (1)

filter

01 XENLETA (1)

filter

01 Yes (1)

URL Supplier Web Content
SOLUTION; INTRAVEN...
EQ 150MG BASE/15ML...
2019-08-19
211673
XENLETA
DISCN
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 211673

Looking for FDA Orange Book APPLICATION 211673 1

19

Nabriva Therapeutics, based in Ireland, is a pharmaceutical company.

One of their notable products is LEFAMULIN ACETATE, with a corresponding application number 211673.

Regulatory Information DISCN

With a dosage strength EQ 150MG BASE/15ML (EQ 10MG BASE/ML)

Dosage Form Route SOLUTION; INTRAVENOUS

Reference Listed Drug Yes

Approved since 2019-08-19

Post Enquiry
POST ENQUIRY